Hanife Bahsi

687 total citations
9 papers, 543 citations indexed

About

Hanife Bahsi is a scholar working on Epidemiology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Hanife Bahsi has authored 9 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 3 papers in Infectious Diseases and 3 papers in Organic Chemistry. Recurrent topics in Hanife Bahsi's work include Cytomegalovirus and herpesvirus research (5 papers), HIV/AIDS drug development and treatment (3 papers) and HIV Research and Treatment (2 papers). Hanife Bahsi is often cited by papers focused on Cytomegalovirus and herpesvirus research (5 papers), HIV/AIDS drug development and treatment (3 papers) and HIV Research and Treatment (2 papers). Hanife Bahsi collaborates with scholars based in Germany, Australia and Croatia. Hanife Bahsi's co-authors include Manfred Marschall, Corina Hutterer, Tony Fröhlich, Svetlana B. Tsogoeva, Isabel Zeitträger, Jens Milbradt, Sabrina Wagner, Thomas Efferth, Christoph Reiter and Barbara Kappes and has published in prestigious journals such as Nature Communications, Antimicrobial Agents and Chemotherapy and PLoS Pathogens.

In The Last Decade

Hanife Bahsi

9 papers receiving 534 citations

Peers

Hanife Bahsi

MB

OC

EPIDE

PHEOH

ONCOL

Isabel Zeitträger Germany

M.D. Rackham United Kingdom

Carla D. Lopes Brazil

Christina Wangen Germany

Sandra K. Freeman United States

Vishal Patel United States

Sandrine Vendeville France

Emanuela Nizi Italy

Eric E. Easom United States

Fred E. Cohen United States

Isabel Zeitträger Germany

Hanife Bahsi

128 ×0.6

MB

87 ×0.5

OC

146 ×0.8

EPIDE

61 ×0.6

PHEOH

56 ×0.7

ONCOL

Citations per year, relative to Hanife Bahsi Hanife Bahsi (= 1×) peers Isabel Zeitträger

Countries citing papers authored by Hanife Bahsi

Since Specialization

Citations

This map shows the geographic impact of Hanife Bahsi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanife Bahsi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanife Bahsi more than expected).

Fields of papers citing papers by Hanife Bahsi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanife Bahsi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanife Bahsi. The network helps show where Hanife Bahsi may publish in the future.

Co-authorship network of co-authors of Hanife Bahsi

This figure shows the co-authorship network connecting the top 25 collaborators of Hanife Bahsi. A scholar is included among the top collaborators of Hanife Bahsi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanife Bahsi. Hanife Bahsi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Held, Felix, Tony Fröhlich, Frank Hampel, et al.. (2017). Facile access to potent antiviral quinazoline heterocycles with fluorescence properties via merging metal-free domino reactions. Nature Communications. 8(1). 15071–15071. 77 indexed citations

2.

Hutterer, Corina, Jens Milbradt, Stuart T. Hamilton, et al.. (2017). Inhibitors of dual-specificity tyrosine phosphorylation-regulated kinases (DYRK) exert a strong anti-herpesviral activity. Antiviral Research. 143. 113–121. 32 indexed citations

3.

Fröhlich, Tony, Christoph Reiter, Mohammad Ibrahim, et al.. (2017). Synthesis of Novel Hybrids of Quinazoline and Artemisinin with High Activities against Plasmodium falciparum, Human Cytomegalovirus, and Leukemia Cells. ACS Omega. 2(6). 2422–2431. 71 indexed citations

4.

Hutterer, Corina, Stuart T. Hamilton, Isabel Zeitträger, et al.. (2016). The chemical class of quinazoline compounds provides a core structure for the design of anticytomegaloviral kinase inhibitors. Antiviral Research. 134. 130–143. 41 indexed citations

5.

Milbradt, Jens, Corina Hutterer, Hanife Bahsi, et al.. (2016). The Prolyl Isomerase Pin1 Promotes the Herpesvirus-Induced Phosphorylation-Dependent Disassembly of the Nuclear Lamina Required for Nucleocytoplasmic Egress. PLoS Pathogens. 12(8). e1005825–e1005825. 43 indexed citations

6.

Sonntag, Eric, Stuart T. Hamilton, Hanife Bahsi, et al.. (2016). Cytomegalovirus pUL50 is the multi-interacting determinant of the core nuclear egress complex (NEC) that recruits cellular accessory NEC components. Journal of General Virology. 97(7). 1676–1685. 36 indexed citations

7.

Reiter, Christoph, Tony Fröhlich, Maen Zeino, et al.. (2015). New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1,2,4-trioxane-ferrocene hybrids. European Journal of Medicinal Chemistry. 97. 164–172. 103 indexed citations

8.

Hutterer, Corina, Jens Milbradt, Tony Fröhlich, et al.. (2015). The broad-spectrum antiinfective drug artesunate interferes with the canonical nuclear factor kappa B (NF-κB) pathway by targeting RelA/p65. Antiviral Research. 124. 101–109. 48 indexed citations

9.

Hutterer, Corina, Jan Eickhoff, Jens Milbradt, et al.. (2015). A Novel CDK7 Inhibitor of the Pyrazolotriazine Class Exerts Broad-Spectrum Antiviral Activity at Nanomolar Concentrations. Antimicrobial Agents and Chemotherapy. 59(4). 2062–2071. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact